ADVANCE phase 3 extension study (ATTAIN): Peginterferon beta-1a 125 mcg every 2 weeks demonstrated sustained efficacy in RMS patients treated up to 5 years Damian Fiore,Serena Hung, Weihua Tang,Yue Cui,Xiaojun You,Shulian Shang,Thomas ScottNEUROLOGY（2016）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
